A1C 9.8% — what it means
An HbA1c of 9.8% corresponds to an estimated average glucose of 235 mg/dL (13.0 mmol/L) and an IFCC value of 84 mmol/mol. Diabetes range
Result summary for an A1C of 9.8%
| Measure | Value |
|---|---|
| NGSP / DCCT A1C | 9.8% |
| IFCC A1C | 84 mmol/mol |
| Estimated average glucose (eAG) | 235 mg/dL |
| eAG in mmol/L | 13.0 mmol/L |
| Category (ADA) | Diabetes range |
| Points from 5.7% prediabetes cut point | +4.1 |
| Points from 6.5% diabetes cut point | +3.3 |
| Points from 7.0% common treatment goal | +2.8 |
| Typical average glucose spread (ADAG 95% CI, interpolated) | 188–275 mg/dL |
High A1C
An A1C of 9.8% reflects an estimated average glucose of about 235 mg/dL (13.0 mmol/L), which is around or above the 180 mg/dL upper limit of the CGM target range most of the time. It is 2.8 points above the common 7% goal.
Sustained glucose at this level raises the risk of eye, kidney and nerve damage and is often accompanied by thirst, frequent urination, fatigue and blurred vision. ADA suggests considering combination therapy when A1C is 1.5 points or more above goal.
Practical next steps
- Contact your clinician soon to adjust treatment.
- Check glucose at home daily until reviewed.
- Ask for kidney (urine albumin, eGFR) and eye screening if not done in the last year.
A1C values near 9.8%
Each 0.1 point of A1C equals about 2.9 mg/dL (0.16 mmol/L) of average glucose and about 1.1 mmol/mol on the IFCC scale.
| A1C | eAG mg/dL | eAG mmol/L | IFCC mmol/mol | Category |
|---|---|---|---|---|
| 8.8% | 206 | 11.4 | 73 | Diabetes range |
| 8.9% | 209 | 11.6 | 74 | Diabetes range |
| 9.0% | 212 | 11.7 | 75 | Diabetes range |
| 9.1% | 214 | 11.9 | 76 | Diabetes range |
| 9.2% | 217 | 12.0 | 77 | Diabetes range |
| 9.3% | 220 | 12.2 | 78 | Diabetes range |
| 9.4% | 223 | 12.4 | 79 | Diabetes range |
| 9.5% | 226 | 12.5 | 80 | Diabetes range |
| 9.6% | 229 | 12.7 | 81 | Diabetes range |
| 9.7% | 232 | 12.8 | 82 | Diabetes range |
| 9.8% | 235 | 13.0 | 84 | Diabetes range |
| 9.9% | 237 | 13.2 | 85 | Diabetes range |
| 10.0% | 240 | 13.3 | 86 | Diabetes range |
| 10.1% | 243 | 13.5 | 87 | Diabetes range |
| 10.2% | 246 | 13.6 | 88 | Diabetes range |
| 10.3% | 249 | 13.8 | 89 | Diabetes range |
| 10.4% | 252 | 13.9 | 90 | Diabetes range |
| 10.5% | 255 | 14.1 | 91 | Diabetes range |
| 10.6% | 258 | 14.3 | 92 | Diabetes range |
| 10.7% | 260 | 14.4 | 93 | Diabetes range |
| 10.8% | 263 | 14.6 | 95 | Diabetes range |
How 9.8% compares with ADA goals
Goals differ by age, health and pregnancy. The ADA sets them individually; the figures below are the default goals in the Standards of Care.
| Group | Goal | This result |
|---|---|---|
| Most non-pregnant adults with diabetes | <7.0% | 2.8 points above |
| Healthy older adults (few chronic illnesses, intact cognition and function) | <7.5% | 2.3 points above |
| Older adults with complex or intermediate health | <8.0% | 1.8 points above |
| Children and adolescents with diabetes | <7.0% | 2.8 points above |
| Pregnancy with pre-existing diabetes | <6.0% | 3.8 points above |
Distance from 9.8% to lower targets
The change in average glucose needed to move from 9.8% to each goal, using the ADAG equation (28.7 mg/dL per A1C point).
| Target A1C | A1C drop | Average glucose drop | Average glucose at target |
|---|---|---|---|
| 8.0% | 1.8 points | 52 mg/dL | 183 mg/dL |
| 7.0% | 2.8 points | 80 mg/dL | 154 mg/dL |
| 6.5% | 3.3 points | 95 mg/dL | 140 mg/dL |
| 5.7% | 4.1 points | 118 mg/dL | 117 mg/dL |
Which weeks shaped this A1C
Hemoglobin glycation follows red blood cell turnover, so recent weeks count more. Kinetic modeling (Tahara and Shima, 1995) found that the most recent 30 days contribute about half of the A1C value. That is why a change in treatment shows up partially after one month and mostly after three.
| Period before the test | Share of A1C | Share of the 235 mg/dL average |
|---|---|---|
| Last 30 days | about 50% | 117 mg/dL weight |
| 30 to 60 days before | about 25% | 59 mg/dL weight |
| 60 to 120 days before | about 25% | 59 mg/dL weight |
When an A1C of 9.8% may not match your meter
- Iron-deficiency anemia can raise A1C; hemolysis, blood loss or a recent transfusion can lower it.
- Advanced chronic kidney disease, dialysis and erythropoietin therapy can lower it.
- Hemoglobin variants such as HbS, HbC or HbE can interfere with some assays; check that your lab method is NGSP-certified and variant-free.
- Late pregnancy lowers A1C because of faster red cell turnover.
Frequently asked questions
Is an A1C of 9.8% good?
An A1C of 9.8% is in the diabetes range (6.5% or higher). For people with diabetes it is 2.8 points above the common 7% goal.
What average blood sugar is an A1C of 9.8%?
Using the ADAG formula eAG = 28.7 × A1C − 46.7, an A1C of 9.8% equals about 235 mg/dL, or 13.0 mmol/L.
What is 9.8% A1C in mmol/mol?
With the IFCC master equation, (9.8 − 2.152) × 10.929 gives 84 mmol/mol.
Is 9.8% A1C diabetes?
Yes, 9.8% is at or above the 6.5% diagnostic threshold, but a diagnosis needs a second abnormal test unless there are clear symptoms with a random glucose of 200 mg/dL or more.
How long does it take to change an A1C of 9.8%?
Because the last 30 days carry about half the weight, a sustained change in average glucose begins to show after about 4 weeks, and most of it is reflected after 8 to 12 weeks. ADA suggests retesting about every 3 months after a treatment change.
Related pages
Sources
- Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values (ADAG Study). Diabetes Care. 2008;31(8):1473-1478.
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 2: Diagnosis and Classification of Diabetes. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 6: Glycemic Goals and Hypoglycemia. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 13: Older Adults. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 14: Children and Adolescents. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 15: Management of Diabetes in Pregnancy. Diabetes Care. 2026;49(Suppl 1).
- Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes. Clin Chem. 2004;50(1):166-174. NGSP/IFCC master equation.
- Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care. 1995;18(4):440-447.
- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
- Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ. 2000;321(7258):405-412.
- National Glycohemoglobin Standardization Program (NGSP). Harmonizing hemoglobin A1c testing; factors that interfere with HbA1c test results.
This page is for education and does not replace advice from your doctor. Diagnosis of diabetes requires laboratory testing and, in most cases, a repeat test.